Use the rate of ventricular dilatation in the treatment of Alzheimer's disease with intravenous immunoglobulin

摘要

The present Invention relates to the use of follow-up MRI ventricular dilatation rate as an objective measure to evaluate disease progression in patients with Alzheimer's disease and for the purpose of determining the therapeutic efficacy of a regime of tra Treatment for Alzheimer's patients.Methods for treating Alzheimer's disease and Control of therapeutic efficacy are provided.